Preview

Minimally Invasive Cardiovascular Surgery

Advanced search

Surgical treatment strategy of patients with cad and moderate ischemic mitral regurgitation

Abstract

Aim: To determine the optimal treatment strategy in patients with coronary artery disease complicated by moderate ischemic mitral regurgitation.

Methods: A total of 80 patients consecutively operated in the Surgical Department of Coronary Artery Disease of the B.V. Petrovsky Russian Scientific Center of Surgery in the period from 2015 to 2022 were included in the study. Of them, 38 patients underwent isolated coronary artery bypass grafting (Group 1) and 42 patients underwent simultaneous coronary artery bypass grafting and mitral valve repair (Group 2). The exclusion criteria were as follows: patients after emergency and repeated surgical interventions, patients operated for postinfarction left ventricular aneurysm.

Results: No significant differences in the perioperative parameters were found in the early postoperative period. There were no deaths in both groups. The most common postoperative complications included respiratory failure (15.8% in Group 1 vs. 23.8% in Group 2, p> 0.05) and arrhythmia (18.4% in Group 1 vs. 28.6% in Group 2, p> 0.05). There were no significant differences in the 7-year survival rate between the groups (94.7% in Group 1 vs. 95% in Group 2, p> 0.05). The freedom from adverse cardiac events did not differ significant as well (53% in Group 1 vs. 66.7% in Group 2, p> 0.05).

Conclusion: A personalized approach based on the quantitative and qualitative assessment of the individual patient status, intracardiac hemodynamic parameters, a detailed analysis of mitral regurgitation, and spatial-geometric ratio of the valve and the left ventricle determine the success of surgical intervention in this group of patients.

About the Authors

I. V. Zhbanov
Federal State Budgetary Scientific Institution “Russian Scientific Center of Surgery named after Academician B.V. Petrovsky”
Russian Federation

Abrikosovsky per., 2, Moscow, 119991



G. A. Revishvili
Federal State Budgetary Scientific Institution “Russian Scientific Center of Surgery named after Academician B.V. Petrovsky”
Russian Federation

Abrikosovsky per., 2, Moscow, 119991



E. N. Aleksandrova
Federal State Budgetary Scientific Institution “Russian Scientific Center of Surgery named after Academician B.V. Petrovsky”
Russian Federation

Abrikosovsky per., 2, Moscow, 119991



B. V. Shabalkin
Federal State Budgetary Scientific Institution “Russian Scientific Center of Surgery named after Academician B.V. Petrovsky”
Russian Federation

Abrikosovsky per., 2, Moscow, 119991



References

1. Grigioni F., Enriquez-Sarano M., Zehr K.J., Bailey K.R., Tajik A.J. Ischemic mitral regurgitation: Long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 2001; 103: 1759–64. DOI: 10.1161/01.CIR.103.13.1759

2. Chernjavskij A.M., Marchenko A.V., Karas’kov A.M.. Surgical treatment of ischemic heart disease complicated by heart failure. Novosibirsk: Geo; 2010. (In Russ).

3. Catherine M. Otto, Rick A. Nishimura, Robert O. Bonow, Blase A. Carabello, John P. Erwin, Federico Gentile, Hani Jneid, Eric V. Krieger, Michael Mack, Christopher McLeod, Patrick T. O’Gara, Vera H. Rigolin, Thoralf M. Sundt, Annemarie Thompson, Christopher Toly, 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/ American Heart Association Joint Committee on Clinical Practice Guidelines,Journal of the American College of Cardiology,Volume 77, Issue 4,2021,Pages e25-e197,ISSN 0735-1097,https://doi.org/10.1016/j.jacc.2020.11.018.

4. Chan K.M., Punjabi P.P., Flather M., Wage R., Symmonds K., Roussin I. et al. Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial. Circulation. 2012; 126 (21): 2502–10. DOI: 10.1161/CIRCULATIONAHA.112.143818

5. Zhang Y., Ma L., Zhao H. Efficacy of mitral valve repair as an adjunct procedure to coronary artery bypass grafting in moderate ischemic mitral regurgitation: a meta-analysis of randomized trials. J. Card. Surg. 2015; 30 (8): 623–30. DOI: 10.1111/jocs.12585

6. Kong F., Pham T., Martin C., Elefteriades J., McKay R., Primiano C., Sun W. Finite element analysis of annuloplasty and papillary muscle relocation on a patient-specific mitral regurgitation model. PLoS One. 2018; 13 (6): e0198331. DOI: 10.1371/journal.pone.0198331

7. Michler R.E., Smith P.K., Parides M.K., Ailawadi G., Thourani V., Moskowitz A.J. et al. Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation. New Engl. J. Med. 2016; 374 (20): 1932–41. DOI: 10.1056/NEJMoa1602003

8. Luzzi C.A., Rao V., Meineri M. Intraoperative 3-dimensional transesophageal echocardiography assessment of valvular geometry after implantation of basal annuloplasty of cardia externally device for ischemic mitral regurgitation. A. A. Pract. 2018; 11 (7): 201–3. DOI: 10.1213/XAA.0000000000000789

9. Rilinger J., Heilmann C., Beitinger U., Olivier C.B., Diehl P., Beyersdorf F., Siepe M. Moderate ischemic mitral regurgitation: coronary artery bypass grafting with versus without simultaneous treatment of the mitral valve. J. Cardiovasc. Surg. (Torino) 2018; 59 (6): 830–5. DOI: 10.23736/S0021-9509.18.10413-7

10. Salmasi M.Y., Harky A., Chowdhury M.F., Abdelnour A., Benjafield A., Suker F. et al. Should the mitral valve be repaired for moderate ischemic mitral regurgitation at the time of revascularization surgery? J. Card. Surg. 2018; 33 (7): 374–84. DOI: 10.1111/jocs.13722

11. Sameer MA, Malik BA, Choudry MOU, Anwar MS, Nadeem MA, Mahmood F, Anwar MZ, Palleti SK. Comparison of Coronary Artery Bypass Grafting Combined With Mitral Valve Repair Versus Coronary Artery Bypass Grafting Alone in Patients With Moderate Ischemic Mitral Regurgitation: A MetaAnalysis. Cureus. 2023 Apr 7;15(4):e37238. doi: 10.7759/cureus.37238. PMID: 37162776; PMCID: PMC10164294.

12. Matsuura K, Kumamaru H, Matsumiya G, Motomura N. Late outcome of coronary artery bypass grafting with or without mitral repair for moderate or moderate-severe ischemic mitral regurgitation. Gen Thorac Cardiovasc Surg. 2023 Mar 28. doi: 10.1007/s11748-023-01925-8. Epub ahead of print. PMID: 36977914.

13. Yin L, Wang Z, Shen H, Min J, Ling X, Xi W. Coronary artery bypass grafting versus combined coronary artery bypass grafting and mitral valve repair in treating ischaemic mitral regurgitation: a metaanalysis. Heart Lung Circ. 2014 Oct;23(10):905-12. doi: 10.1016/j.hlc.2014.03.031. Epub 2014 Apr 18. PMID: 25017041.

14. Zhbanov I.V., Revishvili G.A., Van E.Yu., Kulagina T.Yu., Shabalkin B.V.. Long-term postoperative outcomes in patients with coronary artery disease and ischemic mitral insufficiency. Kardiologiya i SerdechnoSosudistaya Khirurgiya. 2022;15(4):393 401. (In Russ.)

15. Zhbanov I.V., Revishvili G.A., Van E.Yu., Kulagina T.Yu., Aleksandrova E.N., Mazitova D.I., Uryuzhnikov V.V., Shabalkin B.V.. Short-term outcomes of simultaneous coronary artery bypass surgery and mitral valve repair for ischemic mitral insufficiency. Kardiologiya i Serdechno-Sosudistaya Khirurgiya. 2021;14(2):135 144. (In Russ.)

16. Skopin I.I., Vavilov A.V., Slivneva I.V., Latyshev M.S., Sakharov E.R., Kupriy T.A., Chukalin A.S. Immediate results of surgical treatment of functional mitral insufficiency of ischemic origin. The Bulletin of Bakoulev Center. Cardiovascular Diseases. 2019; 20 (9–10): 783–9 (in Russ.).


Review

For citations:


Zhbanov I.V., Revishvili G.A., Aleksandrova E.N., Shabalkin B.V. Surgical treatment strategy of patients with cad and moderate ischemic mitral regurgitation. Minimally Invasive Cardiovascular Surgery. 2024;3(1):11-23. (In Russ.)

Views: 29


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.